IgG Recombinant Rabbit mAb: Precision Detection Tools for Immunoassay Development
Structural and Functional Advantages of IgG Recombinant Rabbit Monoclonal Antibodies
IgG recombinant rabbit monoclonal antibodies are immunoglobulin G molecules derived from the rabbit immune system and produced through genetic engineering for recombinant expression. Their basic structure follows the typical Y-shaped configuration, formed by two identical heavy chains and two identical light chains stably connected through disulfide bonds. Compared with mouse-derived antibodies, the distinctive feature of rabbit-derived antibodies lies in their longer complementarity-determining regions and richer conformational diversity. This enables recombinant rabbit monoclonal antibodies to recognize more hidden or complex antigen epitopes.
The heavy chain variable region and light chain variable region together form the antigen-binding site. The sequence diversity of their hypervariable regions confers the ability to precisely recognize targets. The constant region can be engineered to retain or optimize interactions with effector molecules, Fc receptors, and the complement system. The application of recombinant technology ensures precisely controllable antibody sequences and high batch-to-batch consistency, while permitting humanization or functional enhancement according to application requirements.
Distinctive Value of IgG Recombinant Rabbit Monoclonal Antibodies in Detection Applications
Based on their structural characteristics, IgG recombinant rabbit monoclonal antibodies demonstrate multiple technical advantages in the immunoassay field. In immunohistochemistry, rabbit monoclonal antibodies typically produce stronger signal intensity and lower background noise, making them particularly suitable for detecting low-abundance antigens or targets in paraffin-embedded tissue. In flow cytometry, their high affinity ensures precise recognition of cell surface markers and reduces interference from non-specific binding. In Western blot analysis, recombinant rabbit monoclonal antibodies specifically recognize linear epitopes of denatured proteins while retaining the ability to recognize native conformations. In addition, their multi-platform adaptability allows simultaneous application across enzyme-linked immunosorbent assay, immunofluorescence, and immunoprecipitation systems. These advantages establish IgG recombinant rabbit monoclonal antibodies as core components of research tools and diagnostic reagents.
Therapeutic Potential of IgG Recombinant Rabbit Monoclonal Antibodies
With advances in genetic engineering technology, exploration of IgG recombinant rabbit monoclonal antibodies in the therapeutic field continues to deepen. After humanization modification, the original rabbit-derived antibody sequence retains high affinity while significantly reducing immunogenicity risk, laying the foundation for clinical translation. Their distinctive epitope recognition preference enables targeting of functional epitopes that are difficult to obtain through mouse antibody screening. This offers new possibilities for innovative drug target development.
In antibody-drug conjugate construction, recombinant rabbit monoclonal antibodies can serve as precise delivery vehicles, transporting cytotoxic payloads specifically to tumor cells. In bispecific antibody design, rabbit-derived variable regions can be flexibly combined with other functional modules to create complex antibody formats with multiple mechanisms of action. Furthermore, IgG recombinant rabbit monoclonal antibodies can optimize effector function through Fc engineering. This enables functional conversion from simple blockade to immune activation.
Quality Control System Elements for IgG Recombinant Rabbit Monoclonal Antibodies
Ensuring stable and reliable IgG recombinant rabbit monoclonal antibody quality requires establishing a multi-dimensional quality control system. Verification of sequence accuracy is fundamental, requiring dual confirmation of antibody amino acid sequence identity with the designed sequence through gene sequencing and mass spectrometry. Assessment of structural integrity includes mass spectrometric identification of disulfide bond pairing patterns, circular dichroism analysis of higher-order conformation, and size exclusion chromatographic monitoring of aggregation state. Verification of functional activity requires establishing detection methods separately for the intended application, including affinity determination, specificity validation, and batch-to-batch consistency evaluation. Analysis of glycosylation modification is critical for Fc segment function, requiring detailed characterization of N-glycan composition and distribution. Stability studies must cover the effects of long-term storage, repeated freeze-thaw cycles, and different buffer systems on antibody activity.
Application Areas of IgG Recombinant Rabbit Monoclonal Antibodies in Biomedical Research
The applications of IgG recombinant rabbit monoclonal antibodies have broadly permeated every level of biomedical research. In cell biology research, they can serve as probes to precisely localize subcellular structures and resolve the spatiotemporal distribution of proteins within cells. In signal transduction research, phosphorylation-specific reagents can monitor the activation state of key signaling molecules in real time, revealing the dynamic regulation of signaling pathways.
In the neuroscience field, specific antibodies against neurotransmitter receptors and ion channels provide important tools for resolving neural network function. In tumor research, antibodies against tumor-specific mutant proteins or abnormal modifications support molecular typing and target validation. In infection and immunity research, recombinant rabbit monoclonal antibodies support pathogen antigen detection and immune response profile analysis. In frontier fields such as gene editing and synthetic biology, their value as detection tools continues to expand.
Product Focus: Human IgG Recombinant Rabbit mAb
The Human IgG Recombinant Rabbit mAb (S0B3297) is a monoclonal antibody product with high affinity, broad-spectrum recognition, and excellent stability. It was developed specifically against dual heavy chain and light chain epitopes of human immunoglobulin G. It broadly recognizes whole molecules of all IgG subtypes, including IgG1, IgG2, IgG3, and IgG4, with very low cross-reactivity against IgA and IgM. It is a general-purpose core tool for antibody drug development, immunoassay method establishment, total serum IgG quantification, and diagnostic reagent development.
| Core Advantage | Detailed Description |
|---|---|
| Broad recognition of whole molecules across all IgG subtypes | Through precise antigen design and epitope screening, this product specifically targets the highly conserved conformational epitope of the human IgG molecule. It recognizes the complete molecules of IgG1, IgG2, IgG3, and IgG4 with equal high affinity, ensuring precise detection and quantification of total human IgG in complex biological samples. |
| Dual epitope recognition enhancing detection reliability | This product adopts a heavy chain and light chain dual epitope recognition strategy. Compared with antibodies that recognize only the Fc segment, it identifies intact IgG molecules more stably and maintains consistent detection performance even in partially degraded or conformationally altered samples. |
| Outstanding affinity and sensitivity | Developed on a recombinant rabbit monoclonal antibody platform, the antibody has intrinsic high affinity, verified by SPR and BLI with KD values reaching the nanomolar range. It delivers high-sensitivity, low-background detection across ELISA, Western Blot under reducing and non-reducing conditions, immunodiffusion, immunoturbidimetry, and liquid chip platforms. |
| Multi-platform applicability | Validated for multiple immunoassay platforms, including ELISA for capture and detection, Western Blot under reducing and non-reducing conditions, immunoturbidimetry, immunochromatography, and surface plasmon resonance, and can be flexibly applied to quantitative and qualitative analysis of total human IgG in different experimental scenarios. |
| Excellent stability and batch-to-batch consistency | Produced in a recombinant expression system, the product shows highly consistent performance between batches and stable physicochemical properties, providing stable and reliable raw material support for large-scale diagnostic reagent production, long-term research projects, and multi-center clinical sample analysis. |
| SDT series platform advantage | This product is one of the representative products of the SDT series, undergoing rigorous platform validation and quality control that ensure full-process traceability and performance reliability from research and development through production. |
Detailed technical documentation is available. It includes broad recognition validation data for binding to IgG1, IgG2, IgG3, and IgG4 and subtype cross-reactivity analysis against IgA, IgM, and IgE. Multi-platform application recommendations covering ELISA pairing and Western Blot conditions are also provided, together with affinity constants and typical application cases. A mature rabbit immunization and single B cell antibody platform covers antigen design, immunization optimization, high-throughput single B cell sorting, gene cloning, and recombinant expression. For more details on the Human IgG Recombinant Rabbit mAb (S0B3297), to obtain validation data, or to request a sample test, please contact us. All products are intended for basic research use only.
Related Products
| Catalog No. | Product Name | Target | Epitope Strategy | Recommended Application |
|---|---|---|---|---|
| S0B3297 | Human IgG Recombinant Rabbit mAb (SDT-318-21HL) | Human IgG whole molecule | Heavy and light chain dual epitope | ELISA, WB (reducing and non-reducing), SPR |
| S0B3296 | Human IgG Recombinant Rabbit mAb (SDT-318-203) | Human IgG whole molecule | Conserved conformational epitope | ELISA, WB, Immunoturbidimetry |
ANT BIO PTE. LTD. – Empowering Scientific Breakthroughs
At ANTBIO, we are committed to advancing life science research through high-quality, reliable reagents and comprehensive solutions. Our specialized sub-brands (Starter, Absin, UA) cover a full spectrum of research needs, from general reagents and kits to antibodies and recombinant proteins. With a focus on innovation, quality, and customer-centricity, we strive to be your trusted partner in unlocking scientific mysteries and driving medical progress. Explore our product portfolio today and elevate your research to new heights.
Disclaimer
This article was partially created with the assistance of artificial intelligence. If any content involves copyright or intellectual property issues, please inform us, and we promise to verify and remove it immediately.
